Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy

Detalles Bibliográficos
Autores principales: Rhoades, Ruben, Leong, Ron, Kopenitz, Jason, Thoma, Brandi, McDermott, Lydia, Dovidio, Joseph, Barletti, Shannon, Gong, Jerald Z., Massey, Howard T., McKenzie, Steven E., Rame, J. Eduardo, Al-Rawas, Nawar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Letter to the Editors-in-Chief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053597/
https://www.ncbi.nlm.nih.gov/pubmed/33894473
http://dx.doi.org/10.1016/j.thromres.2021.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053597/
https://www.ncbi.nlm.nih.gov/pubmed/33894473
http://dx.doi.org/10.1016/j.thromres.2021.04.008

Ejemplares similares